The WHY Summit on Partnering and Portfolio Management kicked off yesterday – and what a day of powerful discussions! While much of the focus was on biotech and pharma collaborations, deal acceleration, and strategies for long-term growth, our Head of Expanded Access Program Strategy, Ana Paula Tediosi, wanted to bring the focus back to the patients. In her presentation, “Asset Transition – The Forgotten Patient”, Ana reminded us all that in the midst of complex transitions, regulatory hurdles, and deal-making, we must not lose sight of the patients relying on continued access to treatment. At WEP, we specialize in Expanded Access Programs (EAPs), Compassionate Use Programs (CUPs), and Named Patient Programs (NPPs). We’re proud to support our Sponsors in ensuring that no patient is left behind during these pivotal moments. Let’s keep patients at the center – always. #WithEveryPatient #ExpandedAccess #PatientCentricity #Biotech #Pharma #EAP #WHYsummit #PartneringForPatients
